PHILADELPHIA — Anil K. Rustgi, MD, AGAF, chief of Gastroenterology at the Perelman School of Medicine at the University of Pennsylvania, has been elected President of the American Gastroenterological Association (AGA) Institute. Rustgi’s appointment was announced last week at the annual Digestive Disease Week® (DDW) 2013. He previously served as Vice-President and President-Elect.
Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Instituteadministers the practice, research and educational programs of the organization.
“I’m honored to serve as the next President of the AGA and look forward to leading our specialty and serving its many different constituencies,” said Dr. Rustgi. "My time will be dedicated to issues surrounding NIH funding, health care reform, fund raising for our research foundation that supports young faculty investigators and trainees, supporting relationships with international societies, and promoting the interrelationship between clinical medicine and science.
As a leader in the field of GI cancer research, Dr. Rustgi has made seminal contributions to understanding the mechanisms underlying the development of several major GI cancers, notably esophageal, pancreatic and colorectal cancers. His research is funded through the NIH and other sources. He serves on the advisory boards of the National Colorectal Cancer Research Alliance, Pancreatic Cancer Action Network, National Pancreas Foundation and Caring for Carcinoid Foundation. Dr. Rustgi is an active clinician in the care of patients, especially with GI cancers and genetic disorders. He is also engaged in teaching, mentorship and outreach programs. Former editor-in-chief of Gastroenterology (2006-2011), he has been a member and chair of AGA committees, including the Gastrointestinal Oncology Council Section, the Education and Training Committee, and the Nominating Committee.
For more information, please see the full announcement from the AGA.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.9 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.
Department of Communications
For Patients and the General Public: